Movement Disorder News and Research

Latest Movement Disorder News and Research

Coenzyme Q10 to slow down the effects of Parkinson's disease?

Coenzyme Q10 to slow down the effects of Parkinson's disease?

Neurodegenerative disorders are the second-leading cause of early-onset dementia, says report

Neurodegenerative disorders are the second-leading cause of early-onset dementia, says report

LINGO1 variant responsible for essential tremors and Parkinson's disease

LINGO1 variant responsible for essential tremors and Parkinson's disease

Spinal implant developed by Sanfor Clinic neurosurgeon receives FDA market clearance

Spinal implant developed by Sanfor Clinic neurosurgeon receives FDA market clearance

FDA provides marketing clearance for the spinal implant developed by Sanford Health

FDA provides marketing clearance for the spinal implant developed by Sanford Health

Two-photon microscopy technique tracks calcium levels in mice neurons

Two-photon microscopy technique tracks calcium levels in mice neurons

Positive results obtained from phase 3 clinical trial of lurasidone for treating schizophrenia

Positive results obtained from phase 3 clinical trial of lurasidone for treating schizophrenia

Study reveals that increased neurostimulation market offers growth for device industries

Study reveals that increased neurostimulation market offers growth for device industries

The Parkinson's Disease Foundation and the Davis Phinney Foundation jointly fund new study

The Parkinson's Disease Foundation and the Davis Phinney Foundation jointly fund new study

Possible neurological complications of heart surgery detailed in new report

Possible neurological complications of heart surgery detailed in new report

Neurological complications of heart surgery detailed in research

Neurological complications of heart surgery detailed in research

New discovery about dystonia

New discovery about dystonia

New clues about the roots of neurological disease

New clues about the roots of neurological disease

Deep brain stimulation for psychiatric disorders

Deep brain stimulation for psychiatric disorders

Telemedicine expands reach of care for Parkinson’s patients

Telemedicine expands reach of care for Parkinson’s patients

Biovail acquires worldwide rights to Tetrabenazine

Biovail acquires worldwide rights to Tetrabenazine

Merck Serono starts second phase III trial of Safinamide in advanced Parkinson's

Merck Serono starts second phase III trial of Safinamide in advanced Parkinson's

Shedding some light on Parkinson's treatment

Shedding some light on Parkinson's treatment

Cognitive behavioral therapy helps alleviate nonepileptic seizures

Cognitive behavioral therapy helps alleviate nonepileptic seizures

Deep brain stimulation effective for patients with primary generalized dystonia

Deep brain stimulation effective for patients with primary generalized dystonia